Drug Type AAV based gene therapy |
Synonyms Adeno-Associated Virus 9 vector expressing a wild-type cDNA encoding human Propionyl-CoA Carboxylase, subunit beta (NIH/NCATS) |
Target |
Mechanism PCCB modulators(propionyl-CoA carboxylase subunit beta modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Propionic Acidemia | Preclinical | US | 10 Sep 2024 | |
Propionic Acidemia | Preclinical | US | 10 Sep 2024 |